Optimization of PCR based detection of human papillomavirus DNA from urine specimens

Journal of Clinical Virology

Volumn 29, Issue 4, 2004, Pages 230-240

  Brinkman, Joeli A ^a   Rahmani, Meliha Z ^a   Jones, W Elizabeth ^a,c   Chaturvedi, Anil K ^b   Hagensee, Michael E ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

DNA extraction; HPV; PCR; Urine

Indexed keywords

BETA GLOBIN; NITRITE; PROTEIN; VIRUS DNA;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DILUTION; DNA DETERMINATION; DNA EXTRACTION; FREEZING; GENE AMPLIFICATION; GENETIC ANALYSIS; HUMAN; INHIBITION KINETICS; INTERMETHOD COMPARISON; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SAMPLE; TEMPERATURE; URINALYSIS; URINE; VIRUS GENE; WART VIRUS;

EID: 1442286384     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(03)00157-4     Document Type: Article

References (53)

1. Ackermann S.P., Brackbill R.M., Bewerse B.A., Cheal N.E., Sanderson L.M. Cancer screening behaviors among US women: breast cancer, 1988-1989. MMWR CDC Surveill. Summ. 41:1992;17-25.
2. Anderson L.M. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am. J. Public Health. 85:1995;840-842.
3. Anonymous. National Institutes of Health Consensus Development Conference Statement on Cervical Cancer. April 1-3, 1996. Gynecol Oncol 1996;66:351-361.
4. Baay M.F., Quint W.G., Koudstaal J., Hollema H., Duk J.M., Burger M.P.et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J. Clin. Microbiol. 34:1996;745-747.
5. Baay M.F., Tjalma W.A., Weyler J., Goovaerts G., Buytaert P., Van Marck E.A.et al. Human papillomavirus infection in the female population of Antwerp, Belgium: prevalence in healthy women, women with premalignant lesions and cervical cancer. Eur. J. Gynaecol. Oncol. 22:2001;204-208.
6. Bayer Diagnostics Division. Chemical Measurements. Tarrytown: Bayer Corporation; 1996. p. 35-68.
7. Behzadbehbahani A., Klapper P.E., Vallely P.J., Cleator G.M. Detection of BK virus in urine by polymerase chain reaction: a comparison of DNA extraction methods. J. Virol. Methods. 67:1997;161-166.
8. Berg E.S., Anestad G., Moi H., Storvold G., Skaug K. False-negative results of a ligase chain reaction assay to detect Chlamydia trachomatis due to inhibitors in urine. Eur. J. Clin. Microbiol. Infect Dis. 16:1997;727-731.
9. Boffetta P., Parkin D.M. Cancer in developing countries. CA Cancer J. Clin. 44:1994;81-90.
10. Brinkman J.A., Jones W.E., Gaffga A.M., Sanders J.A., Chaturvedi A.K., Slavinsky J. IIIet al. Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women. J. Clin. Microbiol. 40:2002;3155-3161.
11. Carroll K.C., Aldeen W.E., Morrison M., Anderson R., Lee D., Mottice S. Evaluation of the Abbot LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from sexually transmitted disease clinic population. J. Clin. Microbiol. 36:1998;1630-1633.
12. Chan S.Y., Delius H., Halpern A.L., Bernard H.U. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J. Virol. 69:1995;3074-3083.
13. Chernesky M.A., Jang D., Sellors J., Luinstra K., Chong S., Castriciano S.et al. Urinary inhibitors of polymerase chain reaction and ligase chain reaction and testing of multiple specimens may contribute to lower assay sensitivities for diagnosing Chlamydia trachomatis infected women. Mol. Cell Probes. 11:1997;243-249.
14. Chernesky M., Chong S., Jang D., Luinstra K., Faught M., Mahony J. Inhibition of amplification of Chlamydia trachomatis plasmid DNA by the ligase chain reaction associated with female urines. Clin. Microbiol. Infect. 4:1998;397-404.
15. Crotchfelt K.A., Welsh L.E., DeBonville D., Rosenstraus M., Quinn T.C. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a co-amplification PCR assay. J. Clin. Microbiol. 35:1997;1536-1540.
16. Devesa S.S., Silverman D.T., Young J.L. Jr., Pollack E.S., Brown C.C., Horm J.W. Cancer incidence and mortality trends among whites in the United States, 1947-1984. J. Natl. Cancer Inst. 79:1987;701-770.
17. Echavarria M., Forman M., Ticehurst J., Dumler J.S., Charache P. PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J. Clin. Microbiol. 36:1998;3323-3326.
18. Favre M., Ramoz N., Orth G. Human papillomaviruses: general features. Clin. Dermatol. 15:1997;181-198.
19. Forslund O., Hansson B., Rymark P., Bjerre B. Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples. J. Clin. Microbiol. 31:1993;1975-1979.
20. Fredricks D.N., Relman D.A. Improved amplification of microbial DNA from blood cultures by removal of the PCR inhibitor sodium polyanetholesulfonate. J. Clin. Microbiol. 36:1998;2810-2816.
21. Frye C.A., Weisberg R.B. Increasing the incidence of routine pelvic examinations: behavioral medicine's contribution. Women Health. 21:1994;33-55.
22. Gravitt P.E., Peyton C.L., Apple R.J., Wheeler C.M. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J. Clin. Microbiol. 36:1998;3020-3027.
23. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlee F., Hildesheim A.et al. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38:2000;357-361.
24. Halbert C.L., Galloway D.A. Identification of the E5 open reading frame of human papillomavirus type 16. J. Virol. 62:1988;1071-1075.
25. Hein K., Schreiber K., Cohen M.I., Koss L.G. Cervical cytology: the need for routine screening in the sexually active adolescent. J. Pediatr. 91:1976;123-126.
26. Jacobson D.L., Womack S.D., Peralta L., Zenilman J.M., Feroli K., Maehr J.et al. Concordance of human papillomavirus in the cervix and urine among inner city adolescents. Pediatr. Infect. Dis. J. 19:2000;722-728.
27. Jaschek G., Gaydos C.A., Welsh L.E., Quinn T.C. Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J. Clin. Microbiol. 31:1993;1209-1212.
28. Khan G., Kangro H.O., Coates P.J., Heath R.B. Inhibitory effects of urine on the polymerase chain reaction for cytomegalovirus DNA. J. Clin. Pathol. 44:1991;360-365.
29. Kok T., Wati S., Bayly B., Devonshire-Gill D., Higgins G. Comparison of six nucleic acid extraction methods for detection of viral DNA or RNA sequences in four different non-serum specimen types. J. Clin. Virol. 16:2000;59-63.
30. Koss L.G. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA. 261:1989;737-743.
31. Mahony J.B., Luinstra K.E., Tyndall M., Sellors J.W., Krepel J., Chernesky M. Multiplex PCR for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in genitourinary specimens. J. Clin. Microbiol. 33:1995;3049-3053.
32. Mahony J., Chong S., Jang D., Luinstra K., Faught M., Dalby D.et al. Urine specimens from pregnant and non-pregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J. Clin. Microbiol. 36:1998;3122-3126.
33. Mandelblatt J.S., Lawrence W.F., Gaffikin L., Limpahayom K.K., Lumbiganon P., Warakamin S.et al. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. J. Natl. Cancer Inst. 94:2002;1469-1483.
34. Meisels A. The story of a cell: the George N. Papanicolaou Award Lecture 23. Acta Cytol. 27:1983;584-596.
35. Morre S.A., van Valkengoed I.G., de Jong A., Boeke A.J., van Eijk J.T., Meijer C.J.et al. Mailed, home-obtained urine specimens: a reliable screening approach for detecting asymptomatic Chlamydia trachomatis infections. J. Clin. Microbiol. 37:1999;976-980.
36. Ozbun M.A. Infectious human papillomavirus type 31b: purification and infection of an immortalized human keratinocyte cell line. J. Gen. Virol. 83:2002;2753-2763.
37. Polz M.F., Cavanaugh C.M. Bias in template-to-product ratios in multitemplate PCR. Appl. Environ. Microbiol. 64:1998;3724-3730.
38. Prinz M., Grellner W., Schmitt C. DNA typing of urine samples following several years of storage. Int. J. Legal Med. 106:1993;75-79.
39. Purola E., Savia E. Cytology of gynecologic condyloma acuminatum 22. Acta Cytol. 21:1977;26-31.
40. Reddy D.M., Wasserman S.A. Patient anxiety during gynecologic examinations: behavioral indicators 2. J. Reprod. Med. 42:1997;631-636.
41. Rietmeijer C.A., Yamaguchi K.J., Ortiz C.G., Montstream S.A., LeRoux T., Ehret J.M.et al. Feasibility and yield of screening urine for Chlamydia trachomatis by polymerase chain reaction among high-risk male youth in field-based and other non-clinic settings: a new strategy for sexually transmitted disease control. Sex. Transm. Dis. 24:1997;429-435.
42. Sambrook J, Fritsch EF, Maniatis T, Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1989.
43. Seedorf K., Krammer G., Durst M., Suhai S., Rowekamp W.G. Human papillomavirus type 16 DNA sequence. Virology. 145:1985;181-185.
44. Segnan N. Socioeconomic status and cancer screening. IARC Sci. Publ. 138:1997;369-376.
45. Sellors J.W., Lorincz A.T., Mahony J.B., Mielzynska I., Lytwyn A., Roth P.et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intra-epithelial lesions. CMAJ. 163(5):2000;513-816.
46. Strauss S., Jordens J.Z., McBride D., Sonnex C., Edwards S., Desselberger U. Detection and typing of human papillomavirus DNA in paired urine and cervical scrapes. Eur. J. Epidemiol. 15:1999;537-543.
47. Swan D., Tucker R.A., Tortolero-Luna G.et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol. 37:1999;1030-1034.
48. Ting Y, Manos, MM. Detection and typing of genital human papillomaviruses. In: Innis M, Gelfand D, Sninsky J, White T, editors. PCR protocols: a guide to methods and applications. San Diego, CA: Academic Press Inc.; 1990. p. 356-67.
49. Toye B., Woods W., Bobrowska M., Ramotar K. Inhibition of PCR in genital and urine specimens submitted for Chlamydia trachomatis testing. J. Clin. Microbiol. 36:1998;2356-2358.
50. van der Hel O.L., van der Luijt R.B., Bueno de Mesquita H.B., van Noord P.A., Slothouber B., Roest M.et al. Quality and quantity of DNA isolated from frozen urine in population-based research. Anal. Biochem. 304:2002;206-211.
51. Verkooyen R.P., Luijendijk A., Huisman W.M., Goessens W.H., Kluytmans J.A., van Rijsoort-Vos J.H. Detection of PCR inhibitors in cervical specimens by using the Amplicor Chlamydia trachomatis assay. J. Clin. Microbiol. 34:1996;3072-3074.
52. Vossler J., Forbes B., Adelson M. Evaluation of the polymerase chain reaction for the detection of human papillomavirus from urine. J. Med. Virol. 45:1995;354-360.
53. Whiley D.M., Mackay I.M., Sloots T.P. Detection and differentiation of human polyomaviruses JC and BK by LightCycler PCR. J. Clin. Microbiol. 39:2001;4357-4361.